Lengthy development time has been an ordeal for both life science organizations and the patients who are waiting for the therapy. Information systems available in the market to manage the development content and processes in the industry are mostly inefficient, isolated, or noncompliant. Significant amounts of precious time and fund are wasted, and this is especially true for small and mid-sized life science companies.
